44 results
8-K
EX-4.1
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
transaction solely with respect to such Primary Security, minus (y) with respect to such Secondary Securities, the sum of (I) the Black Scholes Consideration … ) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right, if any, and (III) the fair market value (as reasonably determined jointly
8-K
EX-4.3
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) the Black Scholes Consideration Value of each such Option, if any, (II) the fair market value (as reasonably determined jointly by the Holder … and the Company in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right, if any, and (III) the fair market value
8-K
EX-10.4
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
to such Secondary Securities, the sum of (I) the Black Scholes Consideration Value of each such Option, if any, (II) the fair market value (as reasonably … determined jointly by the Holder and the Company in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right
8-K
EX-4.2
qvd9xkfb5z9265
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.6
gsopeofrcdrbag
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.1
3eps9j
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-4.1
7gwa2hhws0skzckth
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
eo44dlb
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.2
coo377x
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.2
z1k92ffcns
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-4.1
2dm4t46xoej0o
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K/A
EX-99.3
vtfh cewn4otk21o16y
19 Oct 23
Financial Statements and Exhibits
5:23pm
8-K
EX-99.3
k6zgsb5
5 Oct 23
Index to Financial Statements
5:12pm